Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Language
Publication year range
1.
J Thromb Haemost ; 15(4): 774-784, 2017 04.
Article in English | MEDLINE | ID: mdl-28109047

ABSTRACT

Essentials Inhibitors of protein disulfide isomerase (PDI) have been considered a new antithrombotic class. CxxC is a PDI-targeted peptide that has been previously shown to inhibit its reductase activity. CxxC binds to surface PDI and inhibits ADP- and thrombin-evoked platelet activation and aggregation. CxxC binds to Cys400 on CGHC redox motif of PDI a' domain, a site for PDI prothrombotic activity. SUMMARY: Background Protein disulfide isomerase (PDI) plays a major role in platelet aggregation, and its inhibitors have emerged as novel antithrombotic drugs. In previous work, we designed a peptide based on a PDI redox motif (CGHC) that inhibited both PDI reductase activity and PDI-modulated superoxide generation by neutrophil Nox2. Thus, we hypothesized that this peptide would also inhibit platelet aggregation by association with surface PDI. Methods Three peptides were used: CxxC, containing the PDI redox motif; Scr, presenting a scrambled sequence of the same residues and AxxA, with cysteines replaced by alanine. These peptides were tested under platelet aggregation and flow cytometry protocols to identify their possible antiplatelet activity. We labeled membrane free thiol and electrospray ionization liquid chromatography tandem mass spectrometry to test for an interaction. Results CxxC decreased platelet aggregation in a dose-dependent manner, being more potent at lower agonist concentrations, whereas neither AxxA nor Scr peptides exerted any effect. CxxC decreased aIIbb3 activation, but had no effect on the other markers. CxxC also decreased cell surface PDI pulldown without interfering with the total thiol protein content. Finally, we detected the addition of one CxxC molecule to reduced PDI through binding to Cys400 through mass spectrometry. Interestingly, CxxC did not react with oxidized PDI. Discussion CxxC has consistently shown its antiplatelet effects, both in PRP and washed platelets, corroborated by decreased aIIbb3 activation. The probable mechanism of action is through a mixed dissulphide bond with Cys400 of PDI, which has been shown to be essential for PDI's actions. Conclusion In summary, our data support antiplatelet activity for CxxC through binding to Cys400 in the PDI a0 domain, which can be further exploited as a model for sitedriven antithrombotic agent development.


Subject(s)
Platelet Aggregation Inhibitors/chemistry , Procollagen-Proline Dioxygenase/chemistry , Protein Disulfide-Isomerases/chemistry , Alanine/chemistry , Amino Acid Motifs , Blood Platelets/metabolism , Catalytic Domain , Cysteine/chemistry , Disulfides , Humans , Oxidation-Reduction , Peptides/chemistry , Platelet Activation , Platelet Aggregation , Protein Binding , Protein Domains , Protein Folding
2.
Braz J Med Biol Res ; 35(2): 181-90, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11847521

ABSTRACT

Previous studies have shown that exogenously generated nitric oxide (NO) inhibits smooth muscle cell proliferation. In the present study, we stimulated rabbit vascular smooth muscle cells (RVSMC) with E. coli lipopolysaccharide (LPS), a known inducer of NO synthase transcription, and established a connection between endogenous NO, phosphorylation/dephosphorylation-mediated signaling pathways, and DNA synthesis. Non-confluent RVSMC were cultured with 0, 5, 10, or 100 ng/ml of the endotoxin. NO release was increased by 86.6% (maximum effect) in low-density cell cultures stimulated with 10 ng/ml LPS as compared to non-stimulated controls. Conversely, LPS (5 to 100 ng/ml) did not lead to enhanced NO production in multilayered (high density) RVSMC. DNA synthesis measured by thymidine incorporation showed that LPS was mitogenic only to non-confluent RVSMC; furthermore, the effect was prevented statistically by aminoguanidine (AG), a potent inhibitor of the inducible NO synthase, and oxyhemoglobin, an NO scavenger. Finally, there was a cell density-dependent LPS effect on protein tyrosine phosphatase (PTP) and ERK1/ERK2 mitogen-activated protein (MAP) kinase activities. Short-term transient stimulation of ERK1/ERK2 MAP kinases was maximal at 12 min in non-confluent RVSMC and was prevented by preincubation with AG, whereas PTP activities were inhibited in these cells after 24-h LPS stimulation. Conversely, no significant LPS-mediated changes in kinase or phosphatase activities were observed in high-density cells. LPS-induced NO generation by RVSMC may switch on a cell density-dependent proliferative signaling cascade, which involves the participation of PTP and the ERK1/ERK2 MAP kinases.


Subject(s)
DNA/biosynthesis , Escherichia coli , Lipopolysaccharides/pharmacology , Mitogen-Activated Protein Kinases/metabolism , Muscle, Smooth, Vascular/drug effects , Nitric Oxide/metabolism , Protein Tyrosine Phosphatases/metabolism , Animals , Blotting, Western , Cell Count , ErbB Receptors , Muscle, Smooth, Vascular/cytology , Phosphorylation , Precipitin Tests , Rabbits
3.
Braz. j. med. biol. res ; 35(2): 181-190, Feb. 2002. ilus, graf
Article in English | LILACS | ID: lil-303545

ABSTRACT

Previous studies have shown that exogenously generated nitric oxide (NO) inhibits smooth muscle cell proliferation. In the present study, we stimulated rabbit vascular smooth muscle cells (RVSMC) with E. coli lipopolysaccharide (LPS), a known inducer of NO synthase transcription, and established a connection between endogenous NO, phosphorylation/dephosphorylation-mediated signaling pathways, and DNA synthesis. Non-confluent RVSMC were cultured with 0, 5, 10, or 100 ng/ml of the endotoxin. NO release was increased by 86.6 percent (maximum effect) in low-density cell cultures stimulated with 10 ng/ml LPS as compared to non-stimulated controls. Conversely, LPS (5 to 100 ng/ml) did not lead to enhanced NO production in multilayered (high density) RVSMC. DNA synthesis measured by thymidine incorporation showed that LPS was mitogenic only to non-confluent RVSMC; furthermore, the effect was prevented statistically by aminoguanidine (AG), a potent inhibitor of the inducible NO synthase, and oxyhemoglobin, an NO scavenger. Finally, there was a cell density-dependent LPS effect on protein tyrosine phosphatase (PTP) and ERK1/ERK2 mitogen-activated protein (MAP) kinase activities. Short-term transient stimulation of ERK1/ERK2 MAP kinases was maximal at 12 min in non-confluent RVSMC and was prevented by preincubation with AG, whereas PTP activities were inhibited in these cells after 24-h LPS stimulation. Conversely, no significant LPS-mediated changes in kinase or phosphatase activities were observed in high-density cells. LPS-induced NO generation by RVSMC may switch on a cell density-dependent proliferative signaling cascade, which involves the participation of PTP and the ERK1/ERK2 MAP kinases


Subject(s)
Animals , Rabbits , DNA , Lipopolysaccharides , Mitogen-Activated Protein Kinases , Muscle, Smooth, Vascular , Nitric Oxide , Protein Tyrosine Phosphatases , Blotting, Western , Cell Count , Escherichia coli , Phosphorylation , Precipitin Tests , ErbB Receptors
4.
Braz J Med Biol Res ; 30(5): 599-604, 1997 May.
Article in English | MEDLINE | ID: mdl-9283626

ABSTRACT

Aluminum (Al3+) intoxication is thought to play a major role in the development of Alzheimer's disease and in certain pathologic manifestations arising from long-term hemodialysis. Although the metal does not present redox capacity, it can stimulate tissue lipid peroxidation in animal models. Furthermore, in vitro studies have revealed that the fluoroaluminate complex induces diacylglycerol formation, 43-kDa protein phosphorylation and aggregation. Based on these observations, we postulated that Al(3+) -induced blood platelet aggregation was mediated by lipid peroxidation. Using chemiluminescence (CL) of luminol as an index of total lipid peroxidation capacity, we established a correlation between lipid peroxidation capacity and platelet aggregation. Al3+ (20-100 microM) stimulated CL production by human blood platelets as well as their aggregation. Incubation of the platelets with the antioxidants nor-dihydroguaiaretic acid (NDGA) (100 microM) and n-propyl gallate (NPG) (100 microM), inhibitors of the lipoxygenase pathway, completely prevented CL and platelet aggregation. Acetyl salicylic acid (ASA) (100 microM), an inhibitor of the cyclooxygenase pathway, was a weaker inhibitor of both events. These findings suggest that Al3+ stimulates lipid peroxidation and the lipoxygenase pathway in human blood platelets thereby causing their aggregation.


Subject(s)
Aluminum/pharmacology , Lipid Peroxidation/drug effects , Platelet Aggregation/drug effects , Adult , Aluminum/analysis , Guaiacol/analogs & derivatives , Guaiacol/pharmacology , Humans , L-Lactate Dehydrogenase/analysis , Lignans/pharmacology , Luminescent Measurements , Propyl Gallate/pharmacology , Ristocetin/pharmacology , Salicylates/pharmacology
5.
Braz. j. med. biol. res ; 30(5): 599-604, May 1997. tab
Article in English | LILACS | ID: lil-196670

ABSTRACT

Aluminum (Al3+) intoxication is thought to play a major role in the development of Alzheimer's disease and in certain pathologic manifestations arising from long-term hemodialysis. Although the metal does not present redox capacity, it can stimulate tissue lipid peroxidation in animal models. Furthermore, in vitro studies have revealed that the fluoroaluminate complex induces diacyglycerol formation, 43-kDa protein phosphorylation and aggregation. Based on these observations, we postulated that Al3+-induced blood platelet aggregation was mediated by lipid peroxidation. Using chemiluminescence (CL) of luminol as an index of total lipid peroxidation capacity, we established a correlation between lipid peroxidation capacity and platelet aggregation. Al3+ (20-100 muM) stimulated CL production by human blood platelets as well as their aggregation. Incubation of the platelets with the antioxidants nor-dihydroguaiaretic acid (NDGA) (100 muM) and n-propyl gallate (NPG) (100 muM), inhibitors of the lipoxygenase pathway, completely prevented CL and platelet aggregation. Acetyl salicylic acid (ASA) (100 muM), an inhibitor of the cyclooxygenase pathway, was a weaker inhibitor of both events. These findings suggest that Al3+ stimulates lipid peroxidation and the lipoxygenase pathway in human blood platelets thereby causing their aggregation.


Subject(s)
Humans , Adult , Aluminum/pharmacology , L-Lactate Dehydrogenase/analysis , Lignans/pharmacology , Lipid Peroxidation/drug effects , Platelet Aggregation/drug effects , Propyl Gallate/pharmacology , Ristocetin/pharmacology , Salicylates/pharmacology , Aluminum/analysis , Luminescent Measurements
6.
Biochem Biophys Res Commun ; 207(1): 231-7, 1995 Feb 06.
Article in English | MEDLINE | ID: mdl-7857270

ABSTRACT

Incubation of rabbit aortic endothelial cells (RAEC) with oxidized low-density lipoprotein (LDL) for 16 h resulted in stimulation of calcium uptake and increased release of nitric oxide (NO) by these cells. Accompanying inhibition of protein tyrosine phosphatase (PTP) activity in these cells was also observed. Conversely, native LDL was unable to produce any of those effects. These observations suggest that oxidized LDL could modulate two major signalling processes in endothelial cells: tyrosine dephosphorylation and NO synthesis. Such modulation may be of importance in the early phase of the atherogenic process.


Subject(s)
Endothelium, Vascular/metabolism , Lipoproteins, LDL/pharmacology , Nitric Oxide/biosynthesis , Animals , Aorta , Calcium/metabolism , Cells, Cultured , Endothelium, Vascular/drug effects , ErbB Receptors/isolation & purification , ErbB Receptors/metabolism , Humans , Lipoproteins, LDL/blood , Lipoproteins, LDL/isolation & purification , Protein Tyrosine Phosphatases/metabolism , Rabbits , Thiobarbituric Acid Reactive Substances/analysis
7.
Biochem J ; 305 ( Pt 2): 613-9, 1995 Jan 15.
Article in English | MEDLINE | ID: mdl-7530447

ABSTRACT

In the present study, utilizing anti-phosphotyrosine monoclonal antibodies, sodium nitroprusside (SNP) and S-nitroso-N-acetylpenicillamine (SNAP) as sources of NO and murine fibroblasts expressing the human epidermal growth factor (EGF) receptor (HER14 cells), we showed that tyrosine phosphorylation of a set of proteins (126, 56 and 43 kDa) was stimulated when cells were incubated with either SNP or SNAP and abolished by Methylene Blue and oxyhaemoglobin. Inhibition by Methylene Blue suggested an involvement of cyclic GMP in the process, which was evidenced by the effects of 8-bromo cyclic GMP. This analogue of cyclic GMP stimulated tyrosine phosphorylation of the same set of proteins phosphorylated after incubation with the NO source. Tyrosine phosphorylation of the same set of proteins was stimulated when cells were incubated simultaneously with SNP and EGF, showing that NO also potentiates EGF-evoked tyrosine kinase activity in HER14 cells. However, stimulation of the autophosphorylation of the EGF receptor, above the levels obtained for EGF alone, was not observed under those conditions. Additionally, we investigated the effects of NO on EGF-receptor tyrosine phosphatase activities in HER14 cells. Increasing concentrations of NO correlate with a gradual inhibition of these activities in HER14 cells, either in intact cells or in cell lysates. Taken together, these observations suggest that NO modulates tyrosine phosphorylation in HER14 cells.


Subject(s)
Epidermal Growth Factor/metabolism , Nitric Oxide/pharmacology , Phosphoproteins/biosynthesis , Tyrosine/analogs & derivatives , Animals , Cells, Cultured , ErbB Receptors/metabolism , Fibroblasts/metabolism , Humans , Methylene Blue/pharmacology , Mice , Nitroprusside , Oxidation-Reduction , Oxyhemoglobins/pharmacology , Penicillamine/analogs & derivatives , Phosphorylation/drug effects , Phosphotyrosine , Protein Tyrosine Phosphatases/metabolism , Protein-Tyrosine Kinases/metabolism , S-Nitroso-N-Acetylpenicillamine , Tyrosine/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...